|
Market Closed -
OTC Markets
23:57:00 17/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 15.19 USD | +2.86% |
|
+6.82% | +14.30% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
Chart calendar Astellas Pharma Inc.
Upcoming events on Astellas Pharma Inc.
| 29/09/2026 | Ex-dividend date - 40 JPY | 08:00 |
Past events on Astellas Pharma Inc.
| 05/08/2026 | Earnings release - Q1 2027 | 10:30 |
| 05/08/2026 | Earnings presentation | 11:00 |
| 19/06/2026 | Présentation aux Actionnaires / Analystes | 05:00 |
| 19/06/2026 | Annual General Meeting | |
| 03/06/2026 | Analyst/Investor Day | 16:10 |
| 26/05/2026 | Information meeting | 11:00 |
| 15/05/2026 | Board of Directors Meeting | |
| 27/04/2026 | Board of Directors Meeting | |
| 27/04/2026 | Earnings release - Annual 2026 | 10:30 |
| 27/04/2026 | Earnings presentation | 11:00 |
| 31/03/2026 | Information meeting | 04:01 |
| 26/02/2026 | Analyst/Investor Day | 05:00 |
| 04/02/2026 | Earnings release - Q3 2026 | 10:30 |
| 04/02/2026 | Earnings presentation | 11:00 |
| 09/12/2025 | Information meeting | 04:01 |
| 30/10/2025 | Earnings release - Q2 2026 | 10:30 |
| 30/10/2025 | Earnings presentation | 11:15 |
| 24/10/2025 | Information meeting | 04:01 |
Past dividends on Astellas Pharma Inc.
| 30/03/2026 | Ex-dividend date - 39 JPY | 08:00 |
| 29/09/2025 | Ex-dividend date - 39 JPY | 08:00 |
Annual results
| Fiscal Period | March | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 1 603 672 1 571 972 2.02% | 1 912 323 1 879 783 1.73% | 2 139 245 2 132 090 0.34% | 2 338 001 | 2 179 962 | 1 938 212 |
|
EBITDA Million JPY | Released Forecast Spread | 183 358 264 920 -30.79% | 240 171 382 224 -37.16% | 577 227 606 543 -4.83% | 740 737 | 677 049 | 572 836 |
|
EBIT Million JPY | Released Forecast Spread | 25 518 89 542 -71.5% | 41 039 72 914 -43.72% | 382 633 408 040 -6.23% | 490 615 | 461 200 | 374 166 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 24 969 24 853 0.47% | 31 237 53 383 -41.49% | 376 587 374 105 0.66% | 467 128 | 444 618 | 332 782 |
|
Net income Million JPY | Released Forecast Spread | 17 045 13 409 27.12% | 50 747 43 940 15.49% | 291 535 296 438 -1.65% | 361 063 | 339 702 | 256 881 |
|
EPS JPY | Released Forecast Spread | 9,51 13,2 -28.05% | 28,4 24,9 13.75% | 163 171 -4.77% | 210 | 200 | 153 |
| Announcement Date | 25/04/24 | 25/04/25 | 27/04/26 | - |
Quarterly results
| Fiscal Period | March | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 S1 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 462 497 425 282 8.75% | 935 621 916 183 2.12% | 517 408 433 900 19.25% | 459 294 448 340 2.44% | 505 794 466 640 8.39% | 524 320 480 396 9.14% | 1 030 114 945 286 8.97% | 571 206 532 886 7.19% | 537 925 516 347 4.18% | 640 914 561 608 14.12% | 588 232 | 1 242 494 | 613 631 | 537 640 | 515 928 | 1 169 589 |
|
EBITDA Million JPY | Released Forecast Spread | 93 070 59 074 57.55% | -65 027 84 050 -177.37% | 111 203 76 300 45.74% | 142 451 107 950 31.96% | 152 025 128 850 17.99% | 183 638 139 900 31.26% | 99 163 120 397 -17.64% | 234 394 181 450 29.18% | 185 550 | 195 450 | 112 350 | |||||
|
EBIT Million JPY | Released Forecast Spread | 43 053 52 879 -18.58% | 93 710 128 279 -26.95% | -116 191 43 250 -368.65% | 63 520 85 194 -25.44% | 94 647 41 262 129.38% | 104 731 68 833 52.15% | 199 378 60 979 226.96% | 134 502 107 511 25.11% | 48 803 62 750 -22.23% | 184 506 135 080 36.59% | 146 065 | 321 440 | 127 500 | 42 750 | 116 059 | 302 659 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 38 547 57 286 -32.71% | 89 042 124 879 -28.7% | -118 359 77 375 -252.97% | 60 554 225 059 -73.09% | 90 416 35 332 155.9% | 104 190 60 848 71.23% | 194 606 55 979 247.64% | 133 957 102 166 31.12% | 48 024 81 000 -40.71% | 186 514 123 400 51.15% | 148 000 | 318 940 | 129 800 | 35 900 | 113 559 | 297 659 |
|
Net income Million JPY | Released Forecast Spread | 35 908 41 367 -13.2% | 73 511 93 206 -21.13% | -97 660 54 894 -277.91% | 74 896 170 975 -56.19% | 68 422 27 527 148.56% | 79 213 46 074 71.93% | 147 635 48 701 203.15% | 100 379 78 412 28.01% | 43 521 64 329 -32.35% | 141 828 106 592 33.06% | 114 814 | 248 454 | 109 077 | 26 315 | 91 565 | 231 876 |
|
EPS JPY | Released Forecast Spread | 20,1 16,0 25.65% | 41,1 39,4 4.21% | -54,6 8,07 -776.31% | 41,8 4,30 873.37% | 38,2 18,1 111.21% | 44,2 28,9 53.25% | 82,4 27,2 203.09% | 56,0 42,4 32.03% | 24,3 21,4 13.31% | 79,2 51,0 55.32% | 59,3 | 108 | 60,4 | 14,5 | ||
| Announcement Date | 30/10/24 | 30/10/24 | 04/02/25 | 25/04/25 | 30/07/25 | 30/10/25 | 30/10/25 | 04/02/26 | 27/04/26 | 05/08/26 | - | - | - | - | - | - |
| Today |  | Extraordinary General Meeting | 00:30 |
| 20/09/2026 | | Analyst/Investor Day | |
| 21/09/2026 | | Analyst/Investor Day | 15:30 |
| 21/09/2026 | | Annual General Meeting | 09:30 |
| 21/09/2026 | | Présentation aux Actionnaires / Analystes | 09:30 |
| 21/09/2026 | | Annual General Meeting | 09:30 |
| 21/09/2026 | | Présentation aux Actionnaires / Analystes | 09:30 |
| 21/09/2026 | | Board of Directors Meeting | |
| 21/09/2026 | | Earnings release - Q1 2027 | |
| 21/09/2026 | | Ex-dividend date - 4.5 INR | 08:00 |
Past sector events for Astellas Pharma Inc.
| Today | | Présentation aux Actionnaires / Analystes | |
| Today | | Présentation aux Actionnaires / Analystes | |
| Today | | Extraordinary General Meeting | 10:30 |
| Today | | Earnings presentation | 09:00 |
| Today | | Ex-dividend date - 0.2 INR | 08:00 |
| Today | | Extraordinary General Meeting | 10:00 |
| 17/09/2026 | | Information meeting | 18:30 |
| 17/09/2026 | | Présentation aux Actionnaires / Analystes | |
| 17/09/2026 | | Présentation aux Actionnaires / Analystes | 11:00 |
| 17/09/2026 | | Présentation aux Actionnaires / Analystes | 13:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
- Calendar Astellas Pharma Inc.
Select your edition
All financial news and data tailored to specific country editions
